Editas Medicine Stock Probability of Future Stock Price Finishing Over 29.26
| EDIT Stock | USD 5.35 0.11 2.01% |
Closest to current price Editas long CALL Option Payoff at Expiration
Editas |
Editas Medicine Target Price Odds to finish over 29.26
The tendency of Editas Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 29.26 or more in 90 days |
| 5.35 | 90 days | 29.26 | close to zero percent |
Based on a normal probability distribution, the odds of Editas Medicine to move over $ 29.26 or more in 90 days from now is close to zero percent (This Editas Medicine probability density function shows the probability of Editas Stock to fall within a particular range of prices over 90 days) . Probability of Editas Medicine price to stay between its current price of $ 5.35 and $ 29.26 at the end of the 90-day period is about 98.0 .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.65 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Editas Medicine will likely underperform. Additionally Editas Medicine has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite. Editas Medicine Price Density |
| Price |
Predictive Modules for Editas Medicine
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Editas Medicine. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Editas Medicine's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Editas Medicine Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Editas Medicine is not an exception. The market had few large corrections towards the Editas Medicine's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Editas Medicine, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Editas Medicine within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | -0.71 | |
β | Beta against NYSE Composite | 2.65 | |
σ | Overall volatility | 1.15 | |
Ir | Information ratio | -0.11 |
Editas Medicine Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Editas Medicine for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Editas Medicine can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Editas Medicine generated a negative expected return over the last 90 days | |
| Editas Medicine has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 78.12 M. Net Loss for the year was (153.22 M) with loss before overhead, payroll, taxes, and interest of (155.25 M). | |
| Editas Medicine currently holds about 452.56 M in cash with (132.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.59, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 80.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from techtimes.com: AI Makes Photoshop Easier Create, Edit Images Faster with Text Descriptions |
Editas Medicine Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Editas Stock often depends not only on the future outlook of the current and potential Editas Medicine's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Editas Medicine's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 76 M | |
| Cash And Short Term Investments | 323.1 M |
Editas Medicine Technical Analysis
Editas Medicine's future price can be derived by breaking down and analyzing its technical indicators over time. Editas Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Editas Medicine. In general, you should focus on analyzing Editas Stock price patterns and their correlations with different microeconomic environments and drivers.
Editas Medicine Predictive Forecast Models
Editas Medicine's time-series forecasting models is one of many Editas Medicine's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Editas Medicine's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Editas Medicine
Checking the ongoing alerts about Editas Medicine for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Editas Medicine help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Editas Medicine generated a negative expected return over the last 90 days | |
| Editas Medicine has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 78.12 M. Net Loss for the year was (153.22 M) with loss before overhead, payroll, taxes, and interest of (155.25 M). | |
| Editas Medicine currently holds about 452.56 M in cash with (132.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.59, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 80.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from techtimes.com: AI Makes Photoshop Easier Create, Edit Images Faster with Text Descriptions |
Check out Editas Medicine Backtesting, Editas Medicine Valuation, Editas Medicine Correlation, Editas Medicine Hype Analysis, Editas Medicine Volatility, Editas Medicine History as well as Editas Medicine Performance. For more information on how to buy Editas Stock please use our How to Invest in Editas Medicine guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for Editas Stock analysis
When running Editas Medicine's price analysis, check to measure Editas Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Editas Medicine is operating at the current time. Most of Editas Medicine's value examination focuses on studying past and present price action to predict the probability of Editas Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Editas Medicine's price. Additionally, you may evaluate how the addition of Editas Medicine to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Editas Medicine's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Editas Medicine. If investors know Editas will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Editas Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.02) | Revenue Per Share 1.028 | Quarterly Revenue Growth 8.187 | Return On Assets (0.21) | Return On Equity (0.43) |
The market value of Editas Medicine is measured differently than its book value, which is the value of Editas that is recorded on the company's balance sheet. Investors also form their own opinion of Editas Medicine's value that differs from its market value or its book value, called intrinsic value, which is Editas Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Editas Medicine's market value can be influenced by many factors that don't directly affect Editas Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Editas Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Editas Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Editas Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.